AU2001295752A1 - Test for the diagnosis of diabetes and compounds for the treatment thereof - Google Patents

Test for the diagnosis of diabetes and compounds for the treatment thereof

Info

Publication number
AU2001295752A1
AU2001295752A1 AU2001295752A AU9575201A AU2001295752A1 AU 2001295752 A1 AU2001295752 A1 AU 2001295752A1 AU 2001295752 A AU2001295752 A AU 2001295752A AU 9575201 A AU9575201 A AU 9575201A AU 2001295752 A1 AU2001295752 A1 AU 2001295752A1
Authority
AU
Australia
Prior art keywords
diabetes
diagnosis
compounds
test
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295752A
Inventor
David Hosford
Ian James Purvis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2001295752A1 publication Critical patent/AU2001295752A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001295752A 2000-10-19 2001-10-19 Test for the diagnosis of diabetes and compounds for the treatment thereof Abandoned AU2001295752A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0025678.4 2000-10-19
GBGB0025678.4A GB0025678D0 (en) 2000-10-19 2000-10-19 Diagnostic test
PCT/GB2001/004660 WO2002033121A2 (en) 2000-10-19 2001-10-19 Test for the diagnosis of diabetes and compounds for the treatment thereof

Publications (1)

Publication Number Publication Date
AU2001295752A1 true AU2001295752A1 (en) 2002-04-29

Family

ID=9901640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295752A Abandoned AU2001295752A1 (en) 2000-10-19 2001-10-19 Test for the diagnosis of diabetes and compounds for the treatment thereof

Country Status (3)

Country Link
AU (1) AU2001295752A1 (en)
GB (1) GB0025678D0 (en)
WO (1) WO2002033121A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028540A2 (en) * 1999-10-19 2001-04-26 Glaxo Group Limited Agent for treating cephalic pain
WO2001028539A2 (en) * 1999-10-19 2001-04-26 Glaxo Group Limited Agent for treating cephalic pain

Also Published As

Publication number Publication date
WO2002033121A2 (en) 2002-04-25
WO2002033121A3 (en) 2003-10-16
GB0025678D0 (en) 2000-12-06

Similar Documents

Publication Publication Date Title
AU2002241520A1 (en) Blood assessment of injury
AU2002358956A1 (en) Method and device for measuring physiological parameters at the wrist
AU2000276362A1 (en) Composition for the treatment of diabetes
AUPP609198A0 (en) Use of non-peptidyl compounds for the treatment of insulin related ailments
NO20022087L (en) Procedure for the treatment of diabetes
AUPQ886100A0 (en) Diagnostic test
AU2003279442A1 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU5459000A (en) Highly sensitive biological agent probe
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
AU2001248214A1 (en) Device for the introduction of medical items
AU4847499A (en) Compounds and methods for the diagnosis and treatment of (ehrlichia) infection
AU2002254330A1 (en) Blood testing device
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU2002361046A1 (en) Unit for the treatment of histological samples
AU2002309083A1 (en) Method for identifying drugs for the treatment of type ii diabetes
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2001274215A1 (en) Monitor for non-invasive measurement of blood analytes
AU4204700A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2002256053A1 (en) Novel bgp compounds for therapy and diagnosis and methods for using same
AU3460800A (en) Method of bleaching blood samples, diagnostic method and diagnostic kit using the same
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU2002210438A1 (en) Diagnosis of diseases which are associated with cd24
AU2001295752A1 (en) Test for the diagnosis of diabetes and compounds for the treatment thereof
AU2002249891A1 (en) Compounds and methods for the diagnosis and treatment of babesia infection